BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10962552)

  • 21. Inhibition of the activity of SRC and Abl tyrosine protein kinases by the binding of the Wiskott-Aldrich syndrome protein.
    Schulte RJ; Sefton BM
    Biochemistry; 2003 Aug; 42(31):9424-30. PubMed ID: 12899629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cloning, characterization, and expression pattern of Atlantic halibut (Hippoglossus hippoglossus L.) CD4-2, Lck, and ZAP-70.
    Øvergård AC; Nerland AH; Patel S
    Fish Shellfish Immunol; 2010 Dec; 29(6):987-97. PubMed ID: 20728542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous autophosphorylation of Lyn tyrosine kinase at both its activation segment and C-terminal tail confers altered substrate specificity.
    Donella-Deana A; Cesaro L; Ruzzene M; Brunati AM; Marin O; Pinna LA
    Biochemistry; 1998 Feb; 37(5):1438-46. PubMed ID: 9477973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural elements and allosteric mechanisms governing regulation and catalysis of CSK-family kinases and their inhibition of Src-family kinases.
    Ia KK; Mills RD; Hossain MI; Chan KC; Jarasrassamee B; Jorissen RN; Cheng HC
    Growth Factors; 2010 Oct; 28(5):329-50. PubMed ID: 20476842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RACK1: a novel substrate for the Src protein-tyrosine kinase.
    Chang BY; Harte RA; Cartwright CA
    Oncogene; 2002 Oct; 21(50):7619-29. PubMed ID: 12400005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posttranslational regulation of Lck and a p36-38 protein by activators of protein kinase C: differential effects of the tumor promoter, PMA, and the non-tumor-promoter, bryostatin.
    Galron D; Ansotegui IJ; Isakov N
    Cell Immunol; 1997 Jun; 178(2):141-51. PubMed ID: 9225005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Lck SH2 phosphotyrosine binding site is critical for efficient TCR-induced processive tyrosine phosphorylation of the zeta-chain and IL-2 production.
    Lewis LA; Chung CD; Chen J; Parnes JR; Moran M; Patel VP; Miceli MC
    J Immunol; 1997 Sep; 159(5):2292-300. PubMed ID: 9278318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fine-tuning of substrate preferences of the Src-family kinase Lck revealed through a high-throughput specificity screen.
    Shah NH; Löbel M; Weiss A; Kuriyan J
    Elife; 2018 Mar; 7():. PubMed ID: 29547119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Point mutation at single tyrosine residue of novel oncogene NOK abrogates tumorigenesis in nude mice.
    Chen Y; Li YH; Chen XP; Gong LM; Zhang SP; Chang ZJ; Zhang XF; Fu XY; Liu L
    Cancer Res; 2005 Dec; 65(23):10838-46. PubMed ID: 16322230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Docking-based substrate recognition by the catalytic domain of a protein tyrosine kinase, C-terminal Src kinase (Csk).
    Lee S; Ayrapetov MK; Kemble DJ; Parang K; Sun G
    J Biol Chem; 2006 Mar; 281(12):8183-9. PubMed ID: 16439366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutational analysis of Lck in CD45-negative T cells: dominant role of tyrosine 394 phosphorylation in kinase activity.
    D'Oro U; Sakaguchi K; Appella E; Ashwell JD
    Mol Cell Biol; 1996 Sep; 16(9):4996-5003. PubMed ID: 8756658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subdomain X of the kinase domain of Lck binds CD45 and facilitates dephosphorylation.
    Felberg J; Lefebvre DC; Lam M; Wang Y; Ng DH; Birkenhead D; Cross JL; Johnson P
    J Biol Chem; 2004 Jan; 279(5):3455-62. PubMed ID: 14625311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncogenic mutations reduce the stability of SRC kinase.
    Falsone SF; Leptihn S; Osterauer A; Haslbeck M; Buchner J
    J Mol Biol; 2004 Nov; 344(1):281-91. PubMed ID: 15504417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The kinase-dependent function of Lck in T-cell activation requires an intact site for tyrosine autophosphorylation.
    Xu H; Littman DR
    Ann N Y Acad Sci; 1995 Sep; 766():99-116. PubMed ID: 7486706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification of Ser59 in the unique N-terminal region of tyrosine kinase p56lck regulates specificity of its Src homology 2 domain.
    Joung I; Kim T; Stolz LA; Payne G; Winkler DG; Walsh CT; Strominger JL; Shin J
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5778-82. PubMed ID: 7597029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular determinants for Csk-catalyzed tyrosine phosphorylation of the Src tail.
    Wang D; Huang XY; Cole PA
    Biochemistry; 2001 Feb; 40(7):2004-10. PubMed ID: 11329267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tyrosine phosphorylation by Src within the cavity of the adenine nucleotide translocase 1 regulates ADP/ATP exchange in mitochondria.
    Feng J; Lucchinetti E; Enkavi G; Wang Y; Gehrig P; Roschitzki B; Schaub MC; Tajkhorshid E; Zaugg K; Zaugg M
    Am J Physiol Cell Physiol; 2010 Mar; 298(3):C740-8. PubMed ID: 20007455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The unique N-terminal region of SRMS regulates enzymatic activity and phosphorylation of its novel substrate docking protein 1.
    Goel RK; Miah S; Black K; Kalra N; Dai C; Lukong KE
    FEBS J; 2013 Sep; 280(18):4539-59. PubMed ID: 23822091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Lck: evidence for a novel natural Src family kinase inhibitor.
    Zhu S; Fujita DJ; Wang JH
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):546-52. PubMed ID: 21827365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sorting of Fas ligand to secretory lysosomes is regulated by mono-ubiquitylation and phosphorylation.
    Zuccato E; Blott EJ; Holt O; Sigismund S; Shaw M; Bossi G; Griffiths GM
    J Cell Sci; 2007 Jan; 120(Pt 1):191-9. PubMed ID: 17164290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.